MedTrace Logo

A Food Effect Study of SPH5030 Tablets.

NCT06372223 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-04-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the food effect of SPH5030 tablets in healthy Chinese adult subjects.

Conditions

  • Advanced Solid Tumor

Interventions

DRUG

SPH5030

SPH5030 tablets：400mg,orally, Dosing in the fasted state followed by fed dosing.

DRUG

SPH5030

SPH5030 tablets：400mg, orally, Dosing in the fed state followed by fasted dosing.

Sponsors & Collaborators

  • Shanghai Pharmaceuticals Holding Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-04
Primary Completion
2024-03-25
Completion
2024-03-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06372223 on ClinicalTrials.gov